Brookdale Senior Living Inc. annual report, FY2023

Brookdale Senior Living Inc. — FY2023 Form 10-K

Reporting period: Fiscal year ended December 31, 2023. Although the request metadata refers to 2023 Q4, this filing reports full-year results; it does not provide a clear standalone Q4 financial summary.

Business context

Brookdale operated or managed 652 senior living communities in 41 states, with capacity for approximately 59,000 residents. Its services include independent living, assisted living, memory care, and continuing care retirement communities (CCRCs). At year-end, it owned 345 communities, leased 277, and managed 30. Private-pay residents generated 93.7% of resident fee revenue.

Financial and operating metrics

MetricFY2023FY2022Change / context
Resident and management fee revenue$2.867 billion$2.598 billionUp 10.4%
Total revenue and other operating income$3.016 billion$2.825 billionIncludes reimbursed managed-community costs; other operating income fell to $9.1 million from $80.5 million
Net loss$189.1 million$238.3 millionLoss narrowed by $49.3 million
Adjusted EBITDA$335.5 million$241.3 millionUp 39.1%; non-GAAP measure
Net cash from operating activities$162.9 million$3.3 millionImproved substantially
Adjusted Free Cash Flow$(47.6) million$(201.4) millionImproved, but remained negative; non-GAAP measure
Weighted average occupancy77.2%75.4%Up 180 basis points
Same-community RevPAR$4,579$4,110Up 11.4%; occupancy and RevPOR both increased

GAAP operating income was $18.4 million, versus an operating loss of $42.7 million in 2022. The filing does not provide a single clearly stated consolidated profit margin. Results include significant non-cash and transaction-related items, so GAAP and adjusted performance should be considered separately.

Debt, liquidity, and capital

  • Year-end debt was approximately $3.7 billion, at a weighted average rate of 5.58%; $1.5 billion was variable-rate debt, with a weighted average rate of 7.74%. Total interest expense was $238.3 million, up from $204.7 million.
  • Debt obligations included $3.4 billion of non-recourse, property-level mortgages. The company reported $1.0 billion of operating and financing lease obligations on its balance sheet; scheduled future minimum lease payments totaled $1.218 billion.
  • Total liquidity was $340.7 million: $278.0 million unrestricted cash, $29.8 million marketable securities, and $32.9 million available under a secured credit facility. Liquidity declined $111.9 million from year-end 2022. Current liabilities exceeded current assets by $121.7 million.
  • Brookdale reported compliance with debt and lease financial covenants at year-end; certain debt documents require at least $130 million of quarter-end liquidity. Management estimated available sources would fund needs for at least the next 12 months, while noting refinancing and asset-sale uncertainty.
  • All 2024 debt maturities were refinanced. A December 2023 financing included a $179.5 million mortgage loan; the next debt maturity without extension options was stated to be September 2025. On February 9, 2024, Brookdale obtained an additional $50 million variable-rate loan, secured by 11 communities.
  • 2023 net capital expenditures were $218.3 million. Management expected approximately $180 million of 2024 non-development capital expenditures and no planned 2024 development capital expenditures.

Changes, outlook, and material items

  • Revenue growth reflected an 11.4% rise in same-community RevPAR, comprising 8.6% higher RevPOR and a 190-basis-point occupancy increase. Facility operating expense rose 2.2% overall and 3.3% on a same-community basis.
  • Labor costs were about two-thirds of facility operating expense. Same-community labor expense rose 1.2% in 2023, as lower use of premium labor partly offset wage increases; non-labor same-community facility expense rose 7.7%.
  • Higher SOFR materially increased borrowing costs. Management said interest expense on debt rose 32.9%, substantially due to variable-rate debt. About 93% of variable-rate debt had cap or swap coverage at year-end, but those instruments had a weighted average remaining term of 0.8 years.
  • The 2023 net loss included $40.6 million of asset impairment, including a $26.0 million non-cash impairment on the Health Care Services venture interest before its sale for $27.4 million. Brookdale also recognized a $36.3 million net gain on community sales. By contrast, 2022 included a $73.9 million non-cash gain related to a master-lease amendment and substantially higher government grant and credit income.
  • Brookdale sold two owned CCRCs in 2023 and ended triple-net lease obligations on 18 communities. Welltower lease amendments extended the term for 39 communities and changed lease classification for certain properties; these accounting changes affected reported lease expense and cash-flow comparisons.
  • Management’s stated priorities are to restore occupancy and margins toward pre-pandemic levels, grow RevPAR, Adjusted EBITDA, and cash flow, manage expenses, and invest in community upkeep. The 2024 in-place private-pay rate increase was lower than 2023 but still above Brookdale’s typical annual adjustment; management cautioned that rate increases could hinder occupancy recovery or fail to offset costs.
  • Auditors issued an unqualified opinion on the financial statements and internal controls. The critical audit matter was impairment testing of property and lease assets, involving significant assumptions about future cash flows and capitalization rates.

Key risks and contingencies

Principal risks include high leverage and lease commitments; refinancing and interest-rate exposure; dependence on private-pay affordability; occupancy and competition; labor availability and wage inflation; regulatory and reimbursement changes; potential resident claims and self-insured losses; and severe weather, climate, or cybersecurity events. Debt and master-lease cross-default provisions could amplify the consequences of a default. The filing describes pending litigation, including a stockholder derivative action under appeal and another derivative action still pending; it does not identify a specific estimated loss for these matters in the supplied text.

Important facts for investors to verify

  • Whether occupancy and RevPAR gains continue without excessive discounting or adverse effects from resident rate increases.
  • Whether operating cash flow can cover lease payments, debt service, and planned capital spending, given negative Adjusted Free Cash Flow and the working-capital deficit.
  • Refinancing capacity and covenant headroom for 2025 and later maturities, including exposure to variable rates and expiring hedges.
  • The sustainability of Adjusted EBITDA growth after excluding grants, transaction effects, asset-sale gains, and other adjustments; the company reported $9.1 million of grants and credits in 2023 versus $80.5 million in 2022.
  • Potential impairment, self-insurance, litigation, and regulatory exposures, as well as the financial and operating effects of dispositions and lease changes.